J&J set to begin India trial of its single-shot vaccine - report

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday. The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.

Reuters | Washington DC | Updated: 09-04-2021 11:47 IST | Created: 09-04-2021 11:40 IST
J&J set to begin India trial of its single-shot vaccine - report
Representative image Image Credit: ANI

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday.

The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report. (https://bityl.co/6Jif) The report comes as many vaccination centers in India grapple with a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of COVID-19 infections that has eclipsed the first. India's government, however, has repeatedly said there is no shortage of shots.

Johnson & Johnson and the CDSCO did not immediately respond to Reuter's requests for comment. India currently has two approved vaccines in use, one developed by Oxford University and AstraZeneca and the other, a shot from local player Bharat Biotech.

There are other vaccine candidates in trials in India including Russia's Sputnik-V, for which local drugmaker Dr. Reddy is currently conducting trials. Another shot developed by Cadila Healthcare Ltd is also in trials.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Social media suspended in Pakistan, interior ministry says without citing reasons

Social media platforms Twitter, Facebook, YouTube, WhatsApp and Instagram have been suspended in Pakistan from 11 am till 3 pm, the interior ministry said on Friday. The ministry told Geo News that the Pakistan Telecommunication Authority h...

Gunman kills eight, takes own life at FedEx site in Indianapolis -police

A gunman shot eight people dead and injured several others at a FedEx facility in Indianapolis before taking his own life, police said early on Friday.An Indianapolis police officer said the authorities did not feel there was an active thre...

Merkel says lockdowns, curfews vital to break Germany's third wave

German Chancellor Angela Merkel urged lawmakers on Friday to approve new powers that would allow her to force coronavirus lockdowns and curfews on areas with high infection rates, saying a majority of Germans were in favour of stricter meas...

Google misled consumers over data collection - Australian watchdog

Australias federal court found Alphabet Incs Google misled some consumers about personal location data collected through Android mobile devices, the countrys competition regulator said on Friday. The Australian Competition and Consumer Comm...

Give Feedback